Treatment of arterial remodeling in essential hypertension. - Wikidata - awgldk - TriplyDB

Treatment of arterial remodeling in essential hypertension.

Treatment of arterial remodeling in essential hypertension.

http://www.wikidata.org/entity/Q38068360

about

"Smooth Muscle Cell Stiffness Syndrome"-Revisiting the Structural Basis of Arterial Stiffness Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System Association of T174M polymorphism of angiotensinogen gene with essential hypertension: A meta-analysis.Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls.Systolic hypertension: an increasing clinical challenge in Asia Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.Chronic antihypertensive treatment improves pulse pressure but not large artery mechanics in a mouse model of congenital vascular stiffness Hypertensive Vasculopathy: An Exclusive Interview with Dr. Rhian M. Touyz, President of the International Society of Hypertension Vascular Matrix Metalloproteinase Inhibition, a New Mechanism for How Peroxisome Proliferator-Activated Receptor-γ Protects Target Organ Damage.Hypotensive and Angiotensin-Converting Enzyme Inhibitory Activities of Eisenia fetida Extract in Spontaneously Hypertensive Rats.Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats.Efficacy of flavonoids in the management of high blood pressure.Arterial stiffness and decline of renal function in a primary care population.Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.Response: aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins.The Biological Role of Nestin(+)-Cells in Physiological and Pathological Cardiovascular Remodeling.Association between TNF-a promoter -308G/A polymorphism and essential hypertension in the Asian population: A meta-analysis.

P2860

Q26774787-3A80ADA4-7348-4F65-872E-ABA65501C64C Q30275344-A936ED4C-AAB9-4F11-A8EE-B3F3268C00D5 Q33814199-61F9147A-7911-4B43-A683-4C258EE9C607 Q34228484-46B555EC-8F24-4058-A31D-7F568C465D75 Q35178674-CE9A7930-6E76-42B5-855E-660FECB55D16 Q35407610-AC37129C-7CFC-4172-A2B0-194891F1E7D3 Q35611331-462EC5A8-6812-4D52-8EB4-C665A2608DAD Q36114288-5FD5F3CB-D6CC-42B6-8412-DE66418D6AD4 Q36283136-A91D8240-8B62-448A-9B4C-16A30DED2467 Q36373024-63817DBD-4919-44B7-8130-1A3619454909 Q36427247-61AEB4B9-3125-4C4B-B94F-82C5833C686F Q37661093-0F6BFFED-9FFB-4727-9C4C-9149CF76D69F Q38613682-24BF7A95-8A21-48BF-B742-3168B63E903C Q39413423-E3662398-ED52-44B8-AA29-F5B6A7DD2B6B Q39536410-A9758EF9-F2E6-423B-B7A5-4281FEB4F4BE Q43144001-B8085E57-FC42-4314-A4F3-ABADD3CB9931 Q50333784-9A34A2D7-73AE-42EF-8954-99B3D0CBFD3F Q53265538-C8196088-D7CB-4060-8190-C2B0D69E0394

P2860

Treatment of arterial remodeling in essential hypertension.

http://www.wikidata.org/entity/Q38068360

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment of arterial remodeling in essential hypertension.

@en

type

label

Treatment of arterial remodeling in essential hypertension.

@en

prefLabel

Treatment of arterial remodeling in essential hypertension.

@en

P1433

Q38068360-DA9CFEEF-CC18-4CB3-B00A-27B3119D28D8

P1476

Q38068360-E079B074-53E2-4D8F-9E0E-A22515B61BDD

P2093

Q38068360-12889155-69E5-445A-905E-1EABFE333323

Q38068360-CC36BEE5-43A3-4077-BF21-8CDBCC41A9F6

P2860

Q38068360-0FFCCA9E-0150-4488-A056-BDFA3D681C08

Q38068360-11FFD232-2C40-4C8D-819E-636B705021E5

Q38068360-14B1B1C8-10A6-4E2D-9FC5-143DD5508EE9

Q38068360-19CEA298-E056-416C-B1D4-B0D1C7A0A774

Q38068360-1A2A4201-72D3-4A20-9733-0C0963BE08EA

Q38068360-2042ADDE-9AE4-4A1B-9254-1FB8131E4274

Q38068360-30D79EA5-8974-4DB7-99EC-10C7292F2B15

Q38068360-381C8644-D46F-49E3-9262-FA953B6AD9B6

Q38068360-3946F7F6-753E-4E20-9A35-4F5F6470B9C4

Q38068360-4539742B-A641-4A29-9A1B-0B14DD728656

P2888

Q38068360-2264E1E4-FE04-4F3E-BE7C-D1F1868CA4FB

P304

Q38068360-53825BF4-E33B-4FBB-8DF0-5B6A1021FD2A

P31

Q38068360-036F147C-E0FA-4AEF-8348-C12447692E2E

P356

Q38068360-C3BEAAF8-29EF-4272-A548-3C7012216049

P433

Q38068360-1FF9624D-8FF0-4375-BA54-2D0B614414CF

P478

Q38068360-DCC806AB-0E20-4E6A-8E36-392F48044BB6

P577

Q38068360-A6327E88-4250-4E8A-8BB9-6A40021D4C43

P6179

Q38068360-1BBA4560-BA97-4B86-B301-7E6360FA4914

P698

Q38068360-66DD9521-FBB7-4496-AD4E-6E5F6924C942

P921

Q38068360-37AF14DC-7D4C-4FA9-ACBA-4E4F2043C443

P356

S11906-012-0325-0

P1433

Current Hypertension Reports

P1476

Treatment of arterial remodeling in essential hypertension.

@en

P2093

Ernesto L Schiffrin

http://www.w3.org/2001/XMLSchema#string

Marie Briet

http://www.w3.org/2001/XMLSchema#string

P2860

Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus.

Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event.

Analysis of retinal arteriolar structure in never-treated patients with essential hypertension.

Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine.

Arterial destiffening with weight loss in overweight and obese middle-aged and older adults.

Impact of aortic stiffness on survival in end-stage renal disease.

Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients.

Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials.

P2888

s11906-012-0325-0

P304

3-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-012-0325-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034732546

http://www.w3.org/2001/XMLSchema#string

P698

23250721

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension